Sands BE, D'Haens G, Clemow DB, Irving PM, et al. Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. Inflamm Bowel Dis 2024 Oct 25:izae253. doi: 10.1093.
PMID: 39448057